Strain-Specific Genotyping of Bifidobacterium animalis subsp. lactis by Using Single-Nucleotide Polymorphisms,Insertions, and Deletions

Several probiotic strains of Bifidobacterium animalis subsp. lactis are widely supplemented into food products and dietary supplements due to their documented health benefits and ability to survive within the mammalian gastrointestinal tract and acidified dairy products. The strain specificity of these characteristics demands techniques with high discriminatory power to differentiate among strains. However, to date, molecular approaches, such as pulsed-field gel electrophoresis and randomly amplified polymorphic DNA-PCR, have been ineffective at achieving strain separation due to the monomorphic nature of this subspecies. Previously, sequencing and comparison of two B. animalis subsp. lactis genomes (DSMZ 10140 and Bl-04) confirmed this high level of sequence similarity, identifying only 47 single-nucleotide polymorphisms (SNPs) and four insertions and/or deletions (INDELs) between them. In this study, we hypothesized that a sequence-based typing method targeting these loci would permit greater discrimination between strains than previously attempted methods. Sequencing 50 of these loci in 24 strains of B. animalis subsp. lactis revealed that a combination of nine SNPs/INDELs could be used to differentiate strains into 14 distinct genotypic groups. In addition, the presence of a nonsynonymous SNP within the gene encoding a putative glucose uptake protein was found to correlate with the ability of certain strains to transport glucose and to grow rapidly in a medium containing glucose as the sole carbon source. The method reported here can be used in clinical, regulatory, and commercial applications requiring identification of B. animalis subsp. lactis at the strain level.Probiotics are currently defined as live microorganisms which, when administered in adequate amounts, confer a health benefit on the host (12). Many of the organisms studied for their probiotic potential are members of lactic acid bacteria and the genus Bifidobacterium, which has resulted in their inclusion in a large variety of dietary supplements and food products. Relative to most bifidobacterial species of human origin, Bifidobacterium animalis subsp. lactis is less sensitive to stressful conditions (bile, acid, and oxygen) which might be encountered in the mammalian gastrointestinal tract or in fermented or acidified dairy products (7, 26, 28, 31, 37). B. animalis subsp. lactis is widely added to commercial products because it is better able to withstand the adverse conditions of starter culture and product manufacture and to maintain viability and stability during product shelf-life (30). Therefore, strains of B. animalis, specifically B. animalis subsp. lactis, have been found in the majority of probiotic-supplemented dairy products surveyed in North America (the United States and Canada) and Europe (Great Britain, France, Italy, and Germany) (6, 13-15, 21, 22, 28, 29, 32, 49).When selecting a probiotic microorganism to add to supplements or foods, the strain must be identified at the genus, species, and strain levels (40). Proper characterization of a strain is important for safety and quality assurance, for identifying and differentiating putative probiotic strains, and for understanding the interactions among members of gut microbiota. In addition, proper characterization is important to maintain consumer confidence. Product labels often list invalid names of organisms or misidentify the species the product contains, leading to consumer confusion (6, 16, 20, 28, 29, 35, 38, 49). In the case of Bifidobacterium, most dairy products sold in the United States do not identify species, and many only refer to the invalid name “Bifid” or “Bifidus.” At the very least, added microorganisms should be accurately identified to the species level on product labels.According to the FAO/WHO guidelines for probiotic use, specific health benefits observed in research using a specific strain cannot be extrapolated to other, closely related strains (12). Although most clinical studies of probiotic strains compare strains of different genera or different species, few studies have assessed the actual variability of expected health benefits within species or subspecies. However, it is reasonable to consider that health effects, like the phenotypic traits exhibited by strains within a species, are strain specific. Therefore, reliable techniques for the identification of probiotic organisms at the strain level are required.Characterization to the strain level has several important potential applications. Understanding the complex interactions among microorganisms in the intestinal ecosystem requires methods of differentiating a strain of interest from other strains of the same species contained in the autochthonous microbiota. Strain differentiation techniques also aid in assessing survival of a probiotic organism through the gastrointestinal system, which is particularly important for clinical trials and regulatory purposes (17). The ability to uniquely identify a strain also lends credibility to statements made about the potential health benefits of consuming a particular product containing a strain with demonstrated probiotic effects and supports the licensing or intellectual property rights of the manufacturer.The high degree of genome conservation observed between strains of B. animalis subsp. lactis in terms of size, organization, and sequence is indicative of a genomically monomorphic subspecies (2, 25; also HN019 GenBank project 28807). As an example, comparison of the complete genome sequences of two B. animalis subsp. lactis strains, DSMZ 10140 (the type strain) and Bl-04 (a commercial strain, also known as RB 4825) (2), identified 47 single-nucleotide polymorphisms (SNPs) in nonrepetitive elements, as well as 443 bp distributed among four INDEL sites: a 121-bp tRNA-encoding sequence, a 54-bp region within the long-chain fatty acid-coenzyme A ligase gene, a 214-bp region within the CRISPR (clustered regularly interspaced short palindromic repeats) locus, and a 54-bp intergenic sequence. Overall, this 99.975% genome identity explains the inability to differentiate these strains by techniques such as the sequencing of housekeeping genes, multilocus sequence typing, and pulsed-field gel electrophoresis (PFGE) (3, 9, 23, 39, 44-46, 50).The strain specificity of reported health benefits of probiotics and the frequent use of B. animalis subsp. lactis as a probiotic in food products and supplements demands techniques with greater discriminatory power to identify and differentiate among strains within this highly homogeneous group. Unfortunately, strain level differentiation of B. animalis subsp. lactis presents several challenges. Although Ventura and Zink were able to differentiate strains of B. animalis subsp. lactis by sequencing the 16S-23S internal transcribed sequence (ITS) region (47), analysis of the four ITS operons between DSMZ 10140 and Bl-04 indicated complete identity (2). However, SNPs and INDELs do have potential for strain differentiation. According to Achtman, focusing on polymorphic SNPs is a desirable approach for the typing of monomorphic species (1). Therefore, the objective of the present study was to exploit the previously identified SNP and INDEL sites to develop a technique capable of differentiating among a collection of B. animalis subsp. lactis strains obtained from culture collections and commercial starter culture companies.